Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Clinical trial NCT07392528 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07392528
Sponsor: Tianjin Huanhu Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorders Multiple Sclerosis Myasthenia Gravis

Start date: 2026-03-01
Primary completion: 2027-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.